Aug 19, 2024 · Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, severe alopecia areata (hair loss), and COVID-19 in certain patients. These conditions may be caused by an …

Baricitinib has been investigated for its potential to reduce the HIV reservoir and chronic inflammation in people infected with HIV. Preclinical studies in humanized mice and non-human primates have …

Dec 1, 2025 · Baricitinib is used alone or together with other medicines (eg, methotrexate, DMARDs) to treat moderately to severely active rheumatoid arthritis in patients who have taken other medicines …

Baricitinib is a medication that treats rheumatoid arthritis, severe hair loss and COVID-19 by helping your immune system function.

Baricitinib is a disease-modifying antirheumatic drug (DMARD) approved by the FDA to control inflammation in rheumatoid arthritis, alopecia areata, and COVID-19 in adults.

Nov 24, 2024 · Find patient medical information for Olumiant (baricitinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Medscape - Rheumatoid arthritis and COVID-19 dosing for Olumiant (baricitinib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules,...

Baricitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who have not …

Discover Olumiant® (baricitinib), a Janus kinase (JAK) inhibitor, and how Olumiant® works for moderate to severe active Rheumatoid Arthritis (RA).

Dec 12, 2022 · Baricitinib Adult Medication This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to …